Who owns ISIS Pharmaceuticals?

Key details on ISIS Pharmaceuticals (Ticker: ISIS)

Who owns ISIS Pharmaceuticals?

Is ISIS a good stock to own? Find out who bought ISIS Pharmaceuticals, who sold ISIS Pharmaceuticals (ISIS) stock, and who holds a large position in ISIS Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 17.55M $1.12B March 31, 2015
ClearBridge Advisors 9.59M $610.35M March 31, 2015
Vanguard 8.01M $510.19M March 31, 2015
BB Biotech AG 5.73M $364.79M March 31, 2015
Waddell & Reed Financial 5.45M $347.03M March 31, 2015
Columbia Wanger Asset Management 5.08M $71.52M Sept. 30, 2012
BlackRock Fund Advisors 4.59M $292.51M March 31, 2015
Artisan Partners Limited Partnership 3.85M $237.86M Dec. 31, 2014
STATE STREET CORPORATION 3.17M $201.89M March 31, 2015
BlackRock Institutional Trust Company, N.A. 3.16M $201.25M March 31, 2015
T. Rowe Price Associates 2.68M $165.36M Dec. 31, 2014
SUSQUEHANNA INTERNATIONAL 2.60M $100.91M Sept. 30, 2014
EQUITEC SPECIALISTS 2.39M $2.39M Dec. 31, 2014
BVF 2.16M $25.94M June 30, 2012
LORD, ABBETT & CO 2.11M $56.65M June 30, 2013
Tocqueville Asset Management 2.10M $35.50M March 31, 2013
OTR - Nominee Name for The State Teachers Retirement Board of Ohio 2.09M $1.94M March 31, 2015
Franklin Resources 2.07M $127.68M Dec. 31, 2014
Jennison Associates 2.03M $78.90M Sept. 30, 2014
Gail Mannix 2.02M $80.33M Dec. 31, 2013